A Novel Hydrogen Sulfide Donor Reduces Pilocarpine-Induced Status Epilepticus and Regulates Microglial Inflammatory Profile
Although epilepsy is one of the most common neurologic disorders, there is still a lack of effective therapeutic drugs for it. Recently, we synthesized a novel hydrogen sulfide (H2S) donor, which is found to reduce seizures in animal models effectively. But it remains to be determined for its mechan...
Enregistré dans:
Auteurs principaux: | Zhongrui Liu, Ziting Zhu, Yan He, Qiyun Kang, Fei Li, Wenlong Zhang, Yuehua He, Yuwan Lin, Baoyi Huang, Mingshu Mo, Pingyi Xu, Xiaoqin Zhu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4deb0b1dea884317bb4c24f270ce7f5a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Nonconvulsive status epilepticus
Publié: (2009) -
Characterization of mouse salivary polypeptide secretion after oral administration of pilocarpine
par: LÓPEZ-SOLÍS,REMIGIO, et autres
Publié: (2001) -
Combinations of Pilocarpine and Oxymetazoline for the Pharmacological Treatment of Presbyopia
par: Francis W. Price, Jr., MD, et autres
Publié: (2021) -
Substantial outcome improvement using a refined pilocarpine mouse model of temporal lobe epilepsy
par: Alexandre Vigier, et autres
Publié: (2021) -
Status Epilepticus Mortality Risk Factors and a Correlation Survey with the Newly Modified STESS
par: Tzu-Hsin Huang, et autres
Publié: (2021)